Skip to main content
JIANGSU SIHUAN BIOENGINEERING CO.,LTD logo

JIANGSU SIHUAN BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000518 ISIN · CNE0000001P8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,779 across all filing types
Latest filing 2016-08-23 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 000518

About JIANGSU SIHUAN BIOENGINEERING CO.,LTD

https://www.000518shsw.com

Jiangsu Sihuan Bioengineering Co., Ltd. specializes in the research, development, and production of biopharmaceutical products and traditional Chinese medicines. The company’s core product line features genetic engineering drugs, including recombinant human interleukin-2 (rhIL-2) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Its manufacturing capabilities encompass various dosage forms such as injections, capsules, and tablets, adhering to rigorous quality standards. In addition to its pharmaceutical core, the company manages ecological restoration and landscape engineering initiatives. The organization focuses on leveraging biotechnology to provide therapeutic solutions for oncology and immune-related conditions, maintaining a commitment to scientific innovation and clinical efficacy.

Recent filings

Filing Released Lang Actions
独立董事关于关联方资金往来、对外担保情况的专项说明及独立意见
Audit Report / Information Classification · 95% confidence The document is a special statement and independent opinion by independent directors regarding related party transactions and external guarantees, referencing regulatory guidance (证监发（2003）56号文). It contains no financial statements or comprehensive financial data but rather an attestation and opinion on specific compliance matters. The document length is short (534 characters), and it is a standalone statement, not a full audit or annual report. This fits the category of Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles, especially related to internal or regulatory compliance matters. H1 2016
2016-08-23 Chinese
2016年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "江苏四环生物股份有限公司 2016 年半年度报告全文" which translates to "Jiangsu Sihuan Bioengineering Co., Ltd. 2016 Semi-Annual Report Full Text." It contains detailed financial data, management discussion, business overview, financial indicators, and other comprehensive information typical of a semi-annual or interim financial report. The document includes sections such as accounting data, financial indicators, board report, important matters, shareholder information, and financial statements. The length is substantial (15,000 characters), and it contains actual financial data and analysis rather than just an announcement or certification. The document is clearly a comprehensive interim/quarterly report for the half-year period of 2016. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2016
2016-08-23 Chinese
2016年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2016 半年度报告摘要' which translates to '2016 Half-Year Report Summary'. It contains detailed financial data for the half-year period, including revenue, net profit, earnings per share, and asset information. It also includes shareholder information and management discussion and analysis of the financial results and business activities during the period. The document is about 3242 characters long, which is relatively short but contains substantive financial data and analysis, not just an announcement or a certification. The content matches the characteristics of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year and includes actual financial statements and analysis. Therefore, the correct classification is IR (Interim / Quarterly Report). H1 2016
2016-08-23 Chinese
关于涉及诉讼的公告
Legal Proceedings Report Classification · 95% confidence The document is a public announcement by Jiangsu Sihuan Bio Co., Ltd. regarding a litigation case involving a dispute over a shareholder resolution to remove and appoint independent directors. It details the lawsuit's background, parties involved, legal arguments, and potential impact on the company. The document does not contain financial statements or results but focuses on legal proceedings related to corporate governance. It is not an annual report, earnings release, or management report. The content fits the category of Legal Proceedings Report, as it updates on a significant lawsuit involving the company.
2016-08-01 Chinese
2016年半年度业绩预告
Interim / Quarterly Report Classification · 95% confidence The document is a performance forecast for the half-year period ending June 30, 2016, indicating expected loss and preliminary financial estimates. It explicitly states that the forecast is unaudited and that the final data will be in the 2016 half-year report. The document length is short (620 characters), and it serves as an announcement of expected financial results rather than a full financial report. Therefore, it is classified as an Interim / Quarterly Report (IR) because it contains substantive financial data and analysis for a period shorter than a full fiscal year, not merely a notice or publication announcement. H1 2016
2016-07-14 Chinese
关于全资子公司完成工商变更登记事宜的公告
Board/Management Information Classification · 95% confidence The document is a short announcement regarding a change in the legal representative and address of a wholly-owned subsidiary of the company. It does not contain financial data, audit information, or detailed reports. It is an announcement about management changes at the subsidiary level, which aligns with Board/Management Information filings. The document length is very short (378 characters), and it is not a report or a notice of voting results or dividends. Therefore, the best classification is Board/Management Information (MANG).
2016-07-01 Chinese

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.